Published 4 issues per year
ISSN Print: 0731-8898
ISSN Online: 2162-6537
Indexed in
Protective Role of Naringenin Against Doxorubicin-Induced Cardiotoxicity in a Rat Model: Histopathology and mRNA Expression Profile Studies
ABSTRACT
Doxorubicin (DOX) is one of the most effective and widely used chemotherapeutic agents. Its efficacy has been proven in various malignancies alone and combined with other cytocidal agents. However, the clinical usefulness of DOX is restricted by the risk of developing congestive heart failure. Formation of free radicals and oxidative stress during DOX treatment may result in adverse side effects. Naringenin (NAR) is one of the potential bioflavonoids with excellent antioxidant properties and free-radical scavenging capability. This study was designed to evaluate whether NAR exerts a protective role against DOX-induced cardiotoxicity in rats. Male Wistar rats were administered DOX (3 mg/kg) intravenously for 10 consecutive weeks along with oral treatment with NAR (50 mg/kg/day). DOX-induced cardiac toxicity was characterized by the marked biochemical alterations of lactic acid dehydrogenase (LDH), troponin T, malondialdehyde (MDA), reduced cardiac enzymatic activities (SOD, GPx, CAT) and histopathological observations. Administration of NAR to DOX-challenged rats ameliorated alterations in biochemical markers. Indeed, DOX increased the mRNA expression levels of TGF-β1, TNF-α, IL-6, and IL-10 compared with the control group. However, cotreatment with NAR attenuated the mRNA expression levels of these inflammatory markers and improved histological cardiac damage and cardiac functions. Thus, supplementation of NAR may be beneficial in reducing DOX toxicity.
-
Gergely Szabolcs, Hegedűs Csaba, Lakatos Petra, Kovács Katalin, Gáspár Renáta, Csont Tamás, Virág László, High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage, Oxidative Medicine and Cellular Longevity, 2015, 2015. Crossref
-
Chacko Sunitha M., Nevin Kottayath G., Dhanyakrishnan R., Kumar B.Prakash, Protective effect of p -coumaric acid against doxorubicin induced toxicity in H9c2 cardiomyoblast cell lines, Toxicology Reports, 2, 2015. Crossref
-
Adil Mohammad, Kandhare Amit D., Ghosh Pinaki, Bodhankar Subhash L., Sodium arsenite-induced myocardial bruise in rats: Ameliorative effect of naringin via TGF-β/Smad and Nrf/HO pathways, Chemico-Biological Interactions, 253, 2016. Crossref
-
Liu Yan, An Wenjun, Gao Aibao, Protective effects of naringenin in cardiorenal syndrome, Journal of Surgical Research, 203, 2, 2016. Crossref
-
Wang Hui-Lin, Cui Xiao-Hua, Yu Hai-Lun, Wu Rong, Xu Xu, Gao Jian-Ping, Synergistic effects of polydatin and vitamin C in inhibiting cardiotoxicity induced by doxorubicin in rats, Fundamental & Clinical Pharmacology, 31, 3, 2017. Crossref
-
Martinez Renata M., Pinho-Ribeiro Felipe A., Steffen Vinicius S., Silva Thais C. C., Caviglione Carla V., Bottura Carolina, Fonseca Maria J. V., Vicentini Fabiana T. M. C., Vignoli Josiane A., Baracat Marcela M., Georgetti Sandra R., Verri Waldiceu A., Casagrande Rubia, Slominski Andrzej T, Topical Formulation Containing Naringenin: Efficacy against Ultraviolet B Irradiation-Induced Skin Inflammation and Oxidative Stress in Mice, PLOS ONE, 11, 1, 2016. Crossref
-
Kabel Ahmed M., Zinc/alogliptin combination attenuates testicular toxicity induced by doxorubicin in rats: Role of oxidative stress, apoptosis and TGF-β1/NF-κB signaling, Biomedicine & Pharmacotherapy, 97, 2018. Crossref
-
Karim Naymul, Jia Zhenquan, Zheng Xiaodong, Cui Sunliang, Chen Wei, A recent review of citrus flavanone naringenin on metabolic diseases and its potential sources for high yield-production, Trends in Food Science & Technology, 79, 2018. Crossref
-
Zhang Ning, Wei Wen-Ying, Li Ling-Li, Hu Can, Tang Qi-Zhu, Therapeutic Potential of Polyphenols in Cardiac Fibrosis, Frontiers in Pharmacology, 9, 2018. Crossref
-
Hao Yi, Wu Bin, Li Chunguang, Cardioprotective Efficacy of Naringenin Against Isoproterenol Induced Chronic Heart Failure in a Rat Model, International Journal of Pharmacology, 15, 6, 2019. Crossref
-
Shabanah Othman Al-, Ahmed Lulwah Al-, Qunebet Raghad Al-, Yousuf Wejdzan Al-, Mustafa Raghad, Rejaie Salim Al-, Losartan and/or Naringenin Ameliorates Doxorubicin Induced Cardiac, Hepatic and Renal Toxicities in Rats, International Journal of Pharmacology, 15, 6, 2019. Crossref
-
Yu Li-Ming, Dong Xue, Zhang Jian, Li Zhi, Xue Xiao-Dong, Wu Hong-Jiang, Yang Zhong-Lu, Yang Yang, Wang Hui-Shan, Naringenin Attenuates Myocardial Ischemia-Reperfusion Injury via cGMP-PKGIα Signaling and In Vivo and In Vitro Studies, Oxidative Medicine and Cellular Longevity, 2019, 2019. Crossref
-
Wali Adil Farooq, Rashid Summya, Rashid Shahzada Mudasir, Ansari Mushtaq Ahmad, Khan Mohammad Rashid, Haq Nazrul, Alhareth Dhafer Yahya, Ahmad Ajaz, Rehman Muneeb U., Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation, Plants, 9, 4, 2020. Crossref
-
Gao Yanxiang , Wang Zhizhi , Zhang Yayun , Liu Yuting , Wang Shanshan , Sun Weiliang , Guo Jing , Yu Changan , Wang Yong , Kong Wei , Zheng Jingang , Naringenin inhibits NG‑nitro‑L‑arginine methyl ester‑induced hypertensive left ventricular hypertrophy by decreasing angiotensin‑converting enzyme 1 expression, Experimental and Therapeutic Medicine, 2018. Crossref
-
Liu Cun, Ma Xiaoran, Zhuang Jing, Liu Lijuan, Sun Changgang, Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?, Pharmacological Research, 160, 2020. Crossref
-
Naraki Karim, Rezaee Ramin, Karimi Gholamreza, A review on the protective effects of naringenin against natural and chemical toxic agents, Phytotherapy Research, 35, 8, 2021. Crossref
-
Asdaq Syed Mohammed Basheeruddin, Alamri Abdulhakeem S., Alsanie Walaa F., Alhomrani Majid, Cardioprotective Potential of Garlic Oil and Its Active Constituent, Diallyl Disulphide, in Presence of Carvedilol during Chronic Isoprenaline Injection-Mediated Myocardial Necrosis in Rats, Molecules, 26, 17, 2021. Crossref
-
Pateliya Bharat, Burade Vinod, Goswami Sunita, Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study, Naunyn-Schmiedeberg's Archives of Pharmacology, 394, 9, 2021. Crossref
-
Khan Iliyas, Sarkar Bibekananda, Joshi Gaurav, Nakhate Kartik T., Ajazuddin , Mantha Anil K., Kumar Raj, Kaul Ankur, Chaturvedi Shubhra, Mishra Anil K., Gupta Umesh, Biodegradable nanoparticulate co-delivery of flavonoid and doxorubicin: Mechanistic exploration and evaluation of anticancer effect in vitro and in vivo, Biomaterials and Biosystems, 3, 2021. Crossref
-
Navarro-Hortal María D., Varela-López Alfonso, Romero-Márquez José M., Rivas-García Lorenzo, Speranza Lorenza, Battino Maurizio, Quiles José L., Role of flavonoids against adriamycin toxicity, Food and Chemical Toxicology, 146, 2020. Crossref
-
Zhang Xin-Yu, Yang Ke-Lu, Li Yang, Zhao Yang, Jiang Ke-Wei, Wang Quan, Liu Xiao-Nan, Can Dietary Nutrients Prevent Cancer Chemotherapy-Induced Cardiotoxicity? An Evidence Mapping of Human Studies and Animal Models, Frontiers in Cardiovascular Medicine, 9, 2022. Crossref
-
Syahputra Rony Abdi, Harahap Urip, Dalimunthe Aminah, Nasution M. Pandapotan, Satria Denny, The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review, Molecules, 27, 4, 2022. Crossref
-
Ribeiro Ana Paula Dantas, Pereira Amanda Gomes, Todo Márcia Cristina, Fujimori Anderson Seiji Soares, dos Santos Priscila Portugal, Dantas Danielle, Fernandes Ana Angélica, Zanati Silmeia Garcia, Hassimotto Neuza Mariko Aymoto, Zornoff Leonardo Antônio Mamede, Azevedo Paula Schmidt, Minicucci Marcos Ferreira, Paiva Sergio A.R., Polegato Bertha Furlan, Pera orange (Citrus sinensis) and Moro orange (Citrus sinensis (L.) Osbeck) juices attenuate left ventricular dysfunction and oxidative stress and improve myocardial energy metabolism in acute doxorubicin-induced cardiotoxicity in rats, Nutrition, 91-92, 2021. Crossref
-
Li Yuling, Baiyang Li, Leran Bu, Zhen Wang, Yandong Xie, Baixiang Du, Dandan Zhu, Yufu Zhu, Jun Liang, Rutong Yu, Hongmei Liu, Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood–brain barrier and enhance doxorubicin antiglioma effect, Drug Delivery, 24, 1, 2017. Crossref
-
Picos-Salas Manuel Adrian, Cabanillas-Bojórquez Luis Ángel, Elizalde-Romero Cristina Alicia, Leyva-López Nayely, Montoya-Inzunza Luis Aurelio, Heredia J. Basilio, Gutiérrez-Grijalva Erick P., Naringenin as a Natural Agent Against Oxidative Stress and Inflammation, and Its Bioavailability, Food Reviews International, 2022. Crossref